Cell Therapy
BrainStorm cuts 30% staff, eyes ALS cell therapy approval
BrainStorm Cell Therapeutics has chosen an unconventional route in response to its recent setback in securing approval. While the decision ...
Iovanceās cell therapy for skin cancer faces three-year delay due to FDA issues
The FDA has introduced a new twist in the ongoing Iovance Biotherapeutics saga, causing further delays in the approval process ...
Calidi Biotherapeutics goes public through SPAC deal to advance off-the-shelf cancer treatments
Calidi Biotherapeutics, a San Diego-based biotech, has chosen the special purpose acquisition company (SPAC) path to enter the public market, ...
2seventy Bio slashes 176 jobs and looks for new CEO after cell therapy setback
2seventy bio, the spinoff from bluebird bio, is undergoing significant changes under the leadership of CEO Nick Leschly. The company ...
Moderna expands cancer vaccine portfolio with Immatics deal worth up to $1.7B
Moderna is intensifying its focus on cancer vaccines and cell therapies through a newly announced research partnership with Immatics, a ...
BioCardiaās cell therapy fails to improve heart failure outcomes in Phase 3 trial
BioCardia’s attempts to revive its paused phase 3 heart failure trial have hit a major setback, as results fail to ...
Bayer Advances Parkinsonās Cell Therapy to Phase 2 Trial
A new horizon gleams for Bayer’s quest to conquer Parkinson’s disease through advanced cell therapy. In a significant revelation, the ...
Thermo Fisher Cuts Over 200 Jobs at Clinical-Stage Cell and Gene Therapy Facility in Florida
In the midst of ongoing workforce reductions impacting the biotech sector, even prominent players like Bristol Myers Squibb, Emergent BioSolutions, ...
First cell treatment for type I diabetes is approved by the FDA
Source – FDA On June 29, 2023, CellTrans achieved a significant milestone by securing the first-ever FDA approval for a ...
Vertex and Lonza Partner for New Cell Therapy Manufacturing Facility, Creating Job Opportunities
Source – Vertex Pharmaceuticals With promising developments in its experimental cell therapy VX-880 for type I diabetes, Vertex Pharmaceuticals is ...
High Cost of New Cancer Drugs and Lack of Awareness Impede Adoption in the US
A new survey conducted by healthcare research firm Sermo revealed that oncologists in the United States perceive pricing as the ...
AstraZeneca Enters $2 Billion Deal with Quell for Treg Cell Therapy
British start-up Quell Therapeutics has secured a collaboration with AstraZeneca focused on cell therapies for autoimmune diseases, with an upfront ...
